Functional Constipation in Children: Pathophysiology, Diagnosis, and Management
DOI:
https://doi.org/10.14738/bjhmr.112.14478Abstract
Functional constipation (FC) is a common paediatric issue, affecting 3% of children worldwide [1]. The condition can have a significant impact on the quality of life for both children and their families. This review focuses on the current understanding of the pathophysiology, diagnosis, and management of FC in children, with an emphasis on recent advances and guidelines. Recognising and addressing constipation in children is crucial for their overall health and well-being. Due to the unique developmental, behavioural, and physiological differences between children and adults, a tailored and comprehensive approach is essential for effective management in paediatric populations.
References
van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006;101(10):2401-9.
Koppen IJ, Nurko S, Saps M, Di Lorenzo C, Benninga MA. The paediatric Rome IV criteria: what's new? Expert Rev Gastroenterol Hepatol. 2017;11(3):193-201.
Peeters B, Benninga MA, Hennekam RC. Childhood constipation; an overview of genetic studies and associated syndromes. Best Pract Res Clin Gastroenterol. 2011;25(1):73-88.
Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NS, Nurko S. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2016;150(6):1443-1455.e2.
Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, Staiano A, Vandenplas Y, Benninga MA. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-74.
Rajindrajith S, Devanarayana NM. Constipation in children: novel insight into epidemiology, pathophysiology and management. J Neurogastroenterol Motil. 2011;17(1):35-47.
Loening-Baucke V. Functional constipation. Semin Pediatr Surg. 2000;9(3):115-9.
Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9(5):286-94.
Rao SS, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, Scott MS, Simren M, Soffer E, Szarka L. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8-23.
Pezzone MA, Liang R, Fraser MO. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005;128(7):1953-64.
Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011;25(1):3-18.
van Engelenburg-van Lonkhuyzen ML, Bols EM, Benninga MA, Verwijs WA, de Bie RA. Bladder and bowel dysfunction in children: an update on the diagnosis and treatment of a common, but underdiagnosed paediatric problem. Can Urol Assoc J. 2017;11(1-2Suppl1): S64-S72.
Burgers R, Levin AD, Di Lorenzo C, Dijkgraaf MG, Benninga MA. Functional defecation disorders in children: comparing the Rome II with the Rome III criteria. J Pediatr. 2012;161(4):615-620.e1.
Dinning PG, Carrington EV, Scott SM. Colonic and anorectal motility testing in the high-resolution era. Curr Opin Gastroenterol. 2016;32(1):44-8.
Cook IJ, Brookes SJ, Dinning PG. The role of the human brain and the human conscious and unconscious mind in the control of the gastrointestinal tract. Neurogastroenterol Motil. 2012;24(10):893-901.
Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657-64.
Bassotti G, Chistolini F, Sietchiping-Nzepa F, de Roberto G, Morelli A, Chiarioni G. Biofeedback for pelvic floor dysfunction in constipation. BMJ. 2004;328(7436):393-6.
Lee WT, Ip KS, Chan JS, Lui NW, Young BW. Increased prevalence of constipation in pre-school children is attributable to under-consumption of plant foods: A community-based study. J Paediatr Child Health. 2008;44(4):170-5.
Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;150(6):1456-1468.e2.
Zeevenhooven J, Koppen IJ, Benninga MA. The new Rome IV criteria for functional gastrointestinal disorders in infants and toddlers. Pediatr Gastroenterol Hepatol Nutr. 2017;20(1):1-13.
Mugie SM, Di Lorenzo C, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol. 2011;8(9):502-11.
Wright JE, Haslam RRA, O'Donnell B. Factors affecting outcome in the management of chronic idiopathic constipation in childhood. Aust Paediatr J. 1986;22(3):185-8.
Morais MB, Vítolo MR, Aguirre AN, Fagundes-Neto U. Measurement of low dietary fiber intake as a risk factor for chronic constipation in children. J Pediatr Gastroenterol Nutr. 1999;29(2):132-5. Gupta, R. (2024). Functional Constipation in Children: Pathophysiology, Diagnosis, and Management. British Journal of Healthcare and Medical
Pashankar DS, Loening-Baucke V. Increased prevalence of obesity in children with functional constipation evaluated in an academic medical center. Paediatrics. 2005;116(3): e377-80.
Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethylene glycol plus electrolytes (PGE+E) followed by a double-blind comparison of PEG+E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr. 2006;43(1):65-70.
Bekkali N, Hamers SL, Reitsma JB, Van Toledo L, Benninga MA. Infant stool form scale: development and results. J Pediatr. 2009;154(4):521-6. e1.
Castiglia M, Galeotti A, Tontini GE, Settanni M, Benini L, Cortopassi S, Marchetti P, Gazzaniga G. Long-term management of chronic functional constipation in children: a survey of the Italian Society of Paediatric Gastroenterology and Hepatology (SIGENP). Eur J Pediatr. 2019;178(3):393-401.
Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child. 2009;94(2):156-60.
Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus Polyethylene Glycol for Chronic Constipation. Cochrane Database Syst Rev. 2010;(7):CD007570.
Pijpers MA, Tabbers MM, Benninga MA, Berger MY. Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures. Arch Dis Child. 2009;94(2):117-31.
Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr. 2001;139(3):428-32.
Ince BA, Anderson EJ, Neerhof MG. Maternal prenatal and/or postnatal use of laxatives and childhood cancers. Int J Cancer. 1999;80(4):614-8.
Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, Abdelatif A, Baranes C, Benoit S, Benssoussan A, Boussioux JL, Cezard JP, Dabadie A, Gottrand F, Herody M, Lamireau T, Le Luyer B, Ojetti V, Seidman EG, Thapar N, Vandenplas Y, Tounian P. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr. 2005;41(5):625-33.
Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016;(8):CD009118.
Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study. Aliment Pharmacol Ther. 2006;23(10):1479-88.
Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004 Nov;53(11):1590-4.
Gordon M, Naidoo K, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2012;(8):CD009118.
Voskuijl WP, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau JA, Benninga MA. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004;53(11):1590-4.
Bharucha AE, Pemberton JH, Locke GR 3rd. American Gastroenterological Association technical review on constipation. Gastroenterology. 2013;144(1):218-38.
Müller-Lissner S. The pharmacology of sodium Picosulfate. Eur J Gastroenterol Hepatol. 1996;8(Suppl 1): S11-3.
Rajindrajith S, Devanarayana NM. Childhood constipation: a stepwise approach to management. Sri Lanka J Child Health. 2006;35(4):112-9.
Constipation Guideline Committee of the North American Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2006;43(3): e1-13.
Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev. 2014;(3):CD008486.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rajeev Gupta
This work is licensed under a Creative Commons Attribution 4.0 International License.
